Molecular Assessment of Artemisinin Resistance Markers in Eastern and Western Border Areas of Myanmar

Myat Htut Nyunt

Status: Completed

Conditions: Prevalence of Drug Resistance Gene Mutation; Day-3 Positive of Parasitaemia

Study type: Observational

Funder types: Other

Identifiers

NCT02198573

WHO_3DF_2013_day3

Details and patient eligibility

About

• Artemisinin resistance have been documented in Myanmar and Myanmar artemisinin resistance containment measures have been launched since 2009-2010.
• It is important to monitor the spread and magnitude of artemisinin resistant malaria in Myanmar.
• So, day-3 surveillance study have been conducted.
• Recently artemisinin resistant molecular marker, K13 have been identified and it was used as a tool in this study.

Enrollment: 91 patients

Sex: All

Ages: 2+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• confirmed uncomplicated falciparum malaria patients.
• age >2 years
• box sex
• given informed consent

Exclusion criteria

• severe malaria
• did not give informed consent
• others diseases